Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-22-059709
Filing Date
2022-05-13
Accepted
2022-05-12 21:24:41
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 tm2215029-1_s3.htm S-3 642195
2 EXHIBIT 5.1 tm2215029d2_ex5-1.htm EX-5.1 31196
3 EXHIBIT 23.1 tm2215029d2_ex23-1.htm EX-23.1 2464
4 EX-FILING FEES tm2215029d2_ex-filingfees.htm EX-FILING FEES 180345
5 GRAPHIC tm2215029d2_ex5-1img001.gif GRAPHIC 902
6 GRAPHIC tm2215029d2_ex5-1img002.gif GRAPHIC 961
7 GRAPHIC tm2215029d2_ex5-1img003.gif GRAPHIC 4372
8 GRAPHIC tm2215029d2_ex5-1img004.gif GRAPHIC 4392
9 GRAPHIC tm2215029d2_ex5-1img005.gif GRAPHIC 4411
  Complete submission text file 0001104659-22-059709.txt   878818
Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-264911 | Film No.: 22919935
SIC: 2834 Pharmaceutical Preparations